Navigation Links
Quotient Clinical and Bend Research Announce Collaboration to Accelerate Advancement of New Medicines
Date:11/10/2010

BEND, Ore. and NOTTINGHAM, England, Nov. 10, 2010 /PRNewswire/ -- Bend Research Inc. (www.bendres.com), a leading independent drug-formulation development and manufacturing company, and Quotient Clinical, a business unit of Quotient Bioresearch ("Quotient," www.quotientbioresearch.com), a leading developer of compounds through clinical trials, announced today a nonexclusive collaboration that can speed the advance of compounds to clinical trials and expand options for drug delivery.

The collaboration combines Bend Research's advanced drug formulation capabilities and Quotient's clinical-trial design service, RapidFACT™. The result is a clinical-trial program that will allow clients to screen and select optimized formulations rapidly during human testing. For example, optimum bioavailability-enhancing formulations relying on amorphous and nanocrystalline dispersions can be quickly identified using the highly flexible clinical trial designs pioneered by Quotient.

"This collaboration takes advantage of the proven strengths of our two companies," said Bend Research President and CEO Rod Ray. "The versatility of designing and implementing clinical trials using RapidFACT provides our clients with a game-changing advantage in advancing their compounds."

Mark Egerton, Managing Director of Quotient Clinical, agreed on the value of the collaboration. "Poorly soluble compounds are becoming ever more prevalent in the industry's pipeline, and we have many customers who require formulation help to advance such problematic compounds. Access to Bend Research's leading formulation expertise through this collaboration will provide our customers with reliable, rapid and efficient drug formulation platforms," he said.

Accessing Bend Research formulations at Quotient's clinical research site means that clinical studies can happen much more quickly than was previou
'/>"/>

SOURCE Bend Research Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Results of Two New Clinical Studies Show Promise of Emerging Mobile Health Technology to Combat Obesity Epidemic
2. HeartWare Bridge-to-Transplant Data Featured as Late Breaking Clinical Trial at American Heart Association Scientific Sessions 2010
3. AAOS Clinical Guideline for Treating Spinal Compression Fractures Presents More Questions Than Answers for Medical Community
4. US HIFU Announces That 18 Recurrent Prostate Cancer Clinical Trial Sites Are Open For Enrollment
5. New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA)
6. EXTENSION, INC. to Launch Apple iPhone Application for Use in Clinical Workflows
7. New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE® After Inadequate Response to Enbrel® or Humira® Demonstrate Marked Clinical Improvement
8. PAREXEL Expert to Lead Track on Global Clinical Outsourcing at Partnerships in Clinical Trials Europe Conference
9. Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting
10. Sanofi Pasteurs Dengue Vaccine in Final Stage of Clinical Development
11. Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 21, 2014  Publicis Groupe customer engagement agency ... Partner and Healthcare Industry Group Leader, has been featured ... the most inspiring people in the life-sciences industry. Those ... and development, marketing, technology, creativity, strategy and medicine. ... a partner in its leading Rosetta Consulting practice. In ...
(Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - Eisai Limited is pleased ... of the first-of-its-kind comic book available in Canada ... been designed specifically to educate children and their parents about ... affecting more than 300,000 Canadians. Eisai is guided ... (hhc) , in which the patient is central – there ...
(Date:8/21/2014)... Canadian Epilepsy Alliance (CEA) is thrilled to announce the launch ... the most common neurological disorder in Canada ... tells a fictional story based on the experiences of 14-year-old ... "Despite the fact that epilepsy affects 1 ... lack of awareness out there," says Gail Dempsey , ...
Breaking Medicine Technology:Shannon Hartley Shines in PharmaVOICE 100 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 3
... 9, 2011 UCL Business (UCLB), a wholly owned ... Dickinson and Company), a leading global medical technology company, ... detection of ovarian and breast cancers to ultimately enable ... demonstrates how UCL and the Institute for Women,s Health ...
... Feb. 9, 2011 Regeneron Pharmaceuticals, Inc. (Nasdaq: ... an investor briefing on Sunday, February 13 from 9 ... briefing, principal investigators from the VEGF Trap-Eye clinical studies ... Angiogenesis, Exudation and Degeneration 2011 meeting being held in ...
Cached Medicine Technology:BD and UCL Business Reach Exclusive License Agreement to Advance Development of New Diagnostic Tests for Ovarian and Breast Cancers 2BD and UCL Business Reach Exclusive License Agreement to Advance Development of New Diagnostic Tests for Ovarian and Breast Cancers 3BD and UCL Business Reach Exclusive License Agreement to Advance Development of New Diagnostic Tests for Ovarian and Breast Cancers 4Regeneron to Webcast Investor Briefing on VEGF Trap-Eye Clinical Program on Sunday, February 13th at 9 am ET 2Regeneron to Webcast Investor Briefing on VEGF Trap-Eye Clinical Program on Sunday, February 13th at 9 am ET 3Regeneron to Webcast Investor Briefing on VEGF Trap-Eye Clinical Program on Sunday, February 13th at 9 am ET 4Regeneron to Webcast Investor Briefing on VEGF Trap-Eye Clinical Program on Sunday, February 13th at 9 am ET 5
(Date:8/21/2014)... 21, 2014 When children go back to ... can cause them to become sick and risk missing school. ... to help them fight these germs to ensure a successful ... do just that with its XFactor program. , The XFactor ... chewable multi-vitamins. Children ages 4 and up can receive 30-day ...
(Date:8/21/2014)... An international scientific collaboration led by Baylor College ... may contribute to a rare form of kidney cancer, ... but other types as well. , The collaboration, a ... Genome Atlas initiative , completed the sequence of chromophobe ... the journal Cancer Cell . , "The ...
(Date:8/21/2014)... County, NJ (PRWEB) August 21, 2014 ... two leading Radiologists, Amish P. Patel, MD, and ... Our system welcomes Dr. Patel and Dr. Menon ... a comprehensive array of diagnostic imaging services to ... of Bayonne Medical Center, Christ Hospital and Hoboken ...
(Date:8/21/2014)... New Rochelle, NY, August 21, 2014Popular fiction that normalizes ... Fifty Shades series, may be associated with a greater ... results of a provocative new study are presented in ... Associated with Health Risks in Adolescent and Young Adult ... , a peer-reviewed publication from Mary Ann Liebert, Inc., ...
(Date:8/21/2014)... scientists have developed a genetically engineered line of mice ... research on epilepsy, Alzheimer,s and other diseases. , ... degree of fluorescence in response to different calcium levels. ... astrocytes and microglia, to be studied in a new ... decipher how the brain works," said Petr Tvrdik, ...
Breaking Medicine News(10 mins):Health News:MedX Pharmacy Helps with Back to School Preparation 2Health News:Sequence of rare kidney cancer reveals unique alterations involving telomerase 2Health News:Sequence of rare kidney cancer reveals unique alterations involving telomerase 3Health News:Two Top Radiologists Join CarePoint Health 2Health News:Women's health and Fifty Shades: Increased risks for young adult readers? 2Health News:Mouse model for epilepsy, Alzheimer's gives window into the working brain 2
... Do adolescents get enough exercise and eat the right ... Researchers analyzed the behavior of almost 900 11-to-15 year-olds ... and dietary risk behaviors, almost half had at least ... of the health guidelines in the study. ...
... the protein EGFR are important for the development of lung ... However, not all individuals// express the same mutant EGFR, for ... of EGFR and some have a mutation that affects the ... ,The potential of therapeutics to benefit individuals with ...
... The most recent Cochrane Review concluded antidepressants bupropion (Zyban) ... smoking and have few side-effects, but selective Serotonin reuptake ... ,Although nicotine medications are known to ... them or wants to use them. One possible alternative ...
... new report finds that less number of women aged 40 ... declining mammography rate could mean more breast cancer deaths down ... rates kept increasing during the 1990s, and scientists are disturbed ... reminded that, despite mammography being a test that's been around ...
... women who take folic acid supplements during their early pregnancy ... baby up to 40%. The Study results were published in ... ,Folic acid, a synthetic compound of a B vitamin ... neural tube disorders such as spina bifida. But its impact ...
... Scientists at UC Irvine have discovered that learning appears to ... hallmarks of Alzheimer's disease.// The finding suggests that the elderly, ... of this degenerative disease. The study appears in the Jan. ... ,This study with genetically modified mice is the first to ...
Cached Medicine News:Health News:Assessing Diet and Exercise Behaviors in Adolescents 2Health News:Mammography Saves Life-Beware Women Over 40 2Health News:Folic Acid Reduces Risk Of Cleft Lip 2Health News:Learning Slows Physical Progression of Alzheimer's Disease: Study 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: